Beta-blockers for prevention of oesophageal variceal rebleeding in cirrhotic patients-Reference-Cited by-同舟云学术

Beta-blockers for prevention of oesophageal variceal rebleeding in cirrhotic patients

Published:2017-05-03 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Chen Wendong¹,Klingenberg Sarah Louise²,Nikolova Dimitrinka²,Gluud Christian²

Affiliation:

1. Toronto Health Economics and Technology Assessment Collaborative (THETA), University of Toronto; Departments of Health Policy Management and Evaluation, and Pharmacy; Room 679, 6th floor, Leslie L. Dan Pharmacy Building 144 College Street Toronto ON Canada M5S 3M2

2. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004545.pub3/epdf/full

Reference32 articles.

1. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis;Bernard;Hepatology,1997

2. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats;Cales;Journal of Hepatology,1985

3. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol;Cales;Journal of Hepatology,1985

4. Management of bleeding in the cirrhotic patient;Chung;Journal of Gastroenterology and Hepatology,2002

5. Clarke M Oxman AD Cochrane Reviewers’ Handbook 4.2.0 [updated March 2003] The Cochrane Library